Skip to main content
. 2022 Dec 12;6(4):73. doi: 10.3390/vision6040073

Figure 1.

Figure 1

Increase in myopia over three years in the group wearing single-vision spectacle lenses (SV), two years of treatment with 0.01% atropine (A0.01%), and two years wearing dual-focus contact lenses (DFCL) with A0.01% (A0.01% + DFCL). One asterisk (*) represents a significant p value (p < 0.01). SV: single-vision spectacle lenses. A0.01: 0.01% atropine for two years of treatment. A0.01% + DFCL: contact lenses with dual focus and topical 0.01% atropine for two years.